Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Departments of Neurology and Internal Medicine, FLENI, Buenos Aires, Argentina.
Eur J Neurol. 2020 Mar;27(3):579-585. doi: 10.1111/ene.14126. Epub 2019 Dec 8.
The long-term outcomes and stroke recurrence after basilar artery occlusion (BAO) are largely unknown. We aimed to assess these variables in a comparatively large series of consecutive patients.
Adults with acute BAO were retrospectively identified from 1976 to 2011. Post-discharge records were reviewed to assess for stroke recurrences, mortality and disability. Exploratory analysis of survival was carried out using Kaplan-Meier and log-rank tests. Factors associated with survival time were determined using Cox models.
A total of 86 patients (34% female, median age 72 [interquartile range (IQR), 60-79] years) with a median National Institutes of Health Stroke Scale score of 11 (IQR, 6-27) were included. Twenty-nine patients (34%) died during the initial hospitalization. Median modified Rankin Scale (mRS) score at discharge among survivors was 4 (IQR, 2.5-5.5). At 1 and 5 years, 70% of survivors ad a mRS ≤3. Seventeen patients had recurrent strokes during the hospitalization and 12 patients had 19 recurrent strokes after discharge. The median survival time was 52 days (IQR, 6-1846). Older age per decade on admission [adjusted hazard ratios (aHR), 1.32; 95% confidence interval (CI), 1.05-1.66, P = 0.02] and a higher mRS at discharge (aHR, 4.48; 95% CI, 2.72-7.39, P < 0.0001) were associated with mortality. Patients who were not treated with any reperfusion therapy had a trend towards reduced mortality (aHR, 0.39; 95% CI, 0.14-1.08, P = 0.07).
Survivors from BAO had severe short-term functional disability. Most deaths and stroke recurrences occurred within the first year following the initial event. The risk of death was higher in older and more disabled survivors. However, favorable long-term recovery was possible.
基底动脉闭塞(BAO)后的长期预后和卒中复发情况尚不清楚。本研究旨在对一系列连续患者进行评估。
1976 年至 2011 年间,我们回顾性地从所有患者中筛选出急性 BAO 患者。出院后记录用于评估卒中复发、死亡率和残疾情况。采用 Kaplan-Meier 法和对数秩检验进行生存分析。采用 Cox 模型分析与生存时间相关的因素。
共纳入 86 例患者(34%为女性,中位年龄 72 岁[四分位间距(IQR):60-79 岁]),美国国立卫生研究院卒中量表(NIHSS)评分中位数为 11 分(IQR:6-27 分)。29 例(34%)患者在初次住院期间死亡。存活患者出院时改良 Rankin 量表(mRS)评分中位数为 4 分(IQR:2.5-5.5 分)。1 年和 5 年时,70%的存活患者 mRS 评分≤3 分。住院期间有 17 例患者发生卒中复发,出院后有 12 例患者发生 19 次卒中复发。中位生存时间为 52 天(IQR:6-1846 天)。入院时年龄每增加 10 岁[校正风险比(aHR):1.32;95%置信区间(CI):1.05-1.66,P=0.02]和出院时 mRS 评分较高(aHR:4.48;95%CI:2.72-7.39,P<0.0001)与死亡率相关。未接受任何再灌注治疗的患者死亡率降低(aHR:0.39;95%CI:0.14-1.08,P=0.07)。
BAO 幸存者短期功能残疾严重。大多数死亡和卒中复发发生在初始事件后的 1 年内。年龄较大和残疾程度较高的幸存者死亡风险更高。然而,长期恢复情况较好。